SFRP1 and glioblastoma: Thus, to disrupt tumor ASA by modulating cWnt signaling at the Q–A transition, we cloned SFRP1 downstream of the TCF/Lef-promoter in T6 GBM (Fig. 6a and Supplementary Fig. 8a, b; “Methods”).